SBIR-STTR Award

Preclinical Oxygen Imager To Model Efficient Cancer Treatment
Award last edited on: 7/28/2020

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$2,613,595
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Mrignayani Kotecha

Company Information

O2M Technologies LLC

2242 West Harrison Street Suite 201-18
Chicago, IL 60612
   (773) 910-8533
   o2mapinfo@gmail.com
   www.o2map.com
Location: Single
Congr. District: 07
County: Cook

Phase I

Contract Number: 1R43CA224840-01
Start Date: 3/1/2018    Completed: 2/28/2019
Phase I year
2018
Phase I Amount
$298,245
Approximately two third of cancer patients are treated with radiation, either alone or in combination with chemotherapy or surgery. Radiation can damage normal cells and this damage can lead to long-term side effects. Therefore, reduction in overall delivered radiation is beneficial to patients’ quality of life and can potentially save healthcare cost. Oxygen guided radiation therapy (OGRT) is expected to reduce the high radiation dose volume by reducing the dose to well-oxygenated tumor tissue, thus preserving the structure and integrity of irradiated tissues and reducing side effects. Currently, there is no widely available non- invasive clinical or preclinical method to map oxygen partial pressure (pO2) with high accuracy. Available methods either do not provide absolute oxygen measurement deep inside the body, or are not suitable for three-dimensional oxygen map acquisition. Absence of preclinical (animal) oxygen imaging data is the major impediment in development of evidence base for advancing oxygen-based treatments into clinics. Therefore, providing research community with oxygen imaging instruments and services is the first step in achieving these goals. This Phase I SBIR grant will transition the research lab-based low frequency 25 mT (720 MHz) electron paramagnetic resonance oxygen imaging (EPROI) equipment to a commercial benchtop unit, JIVA-25. EPROI is a non-invasive oxygen imaging technique with pO2 resolution of 1-3 torr and spatial resolution of 1 mm. It has been widely applied to map hypoxia in animal solid tumors to evaluate the efficiency of anti-tumor drugs and recently, to guide tumor radiation therapy. In aim 1, we will develop acquisition and image processing software and other accessories that will make JIVA-25, a turnkey instrument, that can be operated by a technician with no prior experience in EPROI. In aim 2, we will construct an oxygen imager prototype, JIVA- 25, and develop standard operating procedure and manual. The success of this proposal will result in a commercial oxygen imager for cancer research in cancer centers, universities and pharmaceutical industry. Our long term goal is to combine this technology with clinical image guided radiation therapy (IMRT) equipment for enhanced and targeted radiation therapy.

Public Health Relevance Statement:
Narrative Oxygen is the single most important molecule for aerobic life forms. No reliable preclinical noninvasive method for three-dimensional molecular oxygen mapping is currently available to scientists for expanding radiation treatment and cancer biology research. This proposal is designed to bridge this gap. We will develop a prototype of oxygen imager based on low frequency electron paramagnetic resonance oxygen imaging (EPROI) technique for preclinical applications.

Project Terms:
Adverse effects; Aerobic; Affect; Amplifiers; Animal Model; Animals; anticancer research; antitumor drug; Area; base; Cancer Biology; Cancer Center; Cancer Patient; cancer therapy; cell injury; chemotherapy; Chicago; Clinic; Clinical; clinical imaging; commercial application; Communication; Communities; Computer software; Computers; cost; Data; design; Development; Dimensions; Dose; drug development; Drug Industry; Electron Spin Resonance Spectroscopy; Electronics; Equipment; evidence base; experience; Frequencies; Future; Goals; Grant; Health Care Costs; Healthcare; Hospitals; Human; Hypoxia; Image; image guided radiation therapy; image processing; image reconstruction; Imaging Device; Imaging Phantoms; Imaging Techniques; Imaging technology; in vivo; instrument; large scale production; Lead; Libraries; Life; Magnetic Resonance Imaging; Manuals; Maps; Measurement; Methods; Mission; Modeling; Molecular; Multimodal Imaging; NCI Center for Cancer Research; Normal Cell; operation; Operative Surgical Procedures; Oxygen; Partial Pressure; Patients; Phase; Physiologic pulse; Physiology; pre-clinical; Procedures; Protocols documentation; prototype; Pythons; Quality of life; Radiation; radiation adverse effect; Radiation therapy; Regenerative Medicine; Research; Resolution; Resources; Scientist; Services; Small Business Innovation Research Grant; Solid Neoplasm; Standardization; Structure; success; System; Techniques; Technology; Three-Dimensional Imaging; Tissues; tool; tumor; Tumor Biology; Tumor Tissue; Universities; user friendly software; user-friendly; Vendor

Phase II

Contract Number: 2R44CA224840-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
(last award dollars: 2020)
Phase II Amount
$2,315,350

This SBIR Phase II proposal is designed to advance the progress made during the SBIR Phase I project “Robust Small Animal Oxygen Imager to Model Enhanced Cancer Treatment”. During Phase I, we have developed a prototype of robust oxygen imager, JIVA-25, for preclinical cancer biology and radiation therapy research. In the current proposal, we plan improvements in hardware, software, and image acquisition methodology that will lead to reduced instrument weight, better instrument performance, and higher resolution oxygen maps. In addition, we will evaluate the JIVA-25 performance with cancer research animal studies that use radiation therapy and drug application. JIVA-25 is a 25 mT oxygen imager with small footprint based on the principles of electron paramagnetic resonance oxygen imaging. JIVA-25 can provide oxygen maps in tissues with 1 mm spatial resolution, 1 torr oxygen resolution and 1-10 min temporal resolution. No other competing method can provide accurate noninvasive pO2 maps with such precision. In tumor, accurate real-time pO2 maps will lead to oxygen guided radiation therapy (OGRT). OGRT is expected to reduce the delivered high radiation dose volume by lowering the dose to well-oxygenated tumor tissues. This will preserve the structure and integrity of irradiated tissues and reduce radiation side effects. The absence of preclinical (animal) oxygen imaging data is the major impediment in the development of evidence base for OGRT translation into clinics. The availability of oxygen maps in preclinical settings is also expected to lead to advanced drug and radiation therapies. Providing the research community with JIVA-25 instrument is the first step in achieving these goals.

Public Health Relevance Statement:
Narrative Oxygen is the single most important molecule for aerobic life forms. No reliable preclinical noninvasive method for three-dimensional molecular oxygen mapping is currently available to scientists for expanding radiation treatment and cancer biology research. This proposal is designed to bridge this gap. We will develop a market-ready preclinical oxygen imager JIVA-25 based on low frequency electron paramagnetic resonance oxygen imaging (EPROI) methodology for cancer research.

NIH Spending Category:
Bioengineering; Cancer; Radiation Oncology

Project Terms:
Aerobic; Allografting; Animal Experimentation; Animals; anticancer research; base; Breast Cancer Model; Cancer Biology; cancer imaging; cancer therapy; Cells; Certificate of Need; Certification; Chicago; Clinic; Communication; Communities; Complex; Computer software; computerized data processing; Data; data acquisition; design; Development; Device or Instrument Development; Devices; Dimensions; Dose; Drug Combinations; Electron Spin Resonance Spectroscopy; Environment; Evaluation; evidence base; experience; Freezing; Frequencies; Future; Goals; Grant; Human; Hypoxia; Image; imager; Imaging technology; innovation; instrument; instrumentation; International; Interview; Laboratories; Laws; Lead; Life; Malignant Neoplasms; Maps; Measurement; Measures; Methodology; Methods; Modeling; Molecular; mouse model; Mus; NCI Center for Cancer Research; Oxygen; Papaverine; Performance; Pharmaceutical Preparations; Pharmacotherapy; Phase; phase 2 designs; Physiologic pulse; pre-clinical; preservation; programs; Protocols documentation; prototype; Radiation; radiation delivery; Radiation Dose Unit; radiation response; Radiation therapy; Recommendation; Regenerative Medicine; Research; Resistance; Resolution; response; sarcoma; Scientist; side effect; Small Business Innovation Research Grant; Soft tissue sarcoma; Structure; Technology; temporal measurement; Testing; Therapeutic Studies; Time; Tissue Engineering; Tissues; tool development; touchscreen; Translations; Treatment Protocols; tumor; Tumor Biology; tumor hypoxia; Tumor Tissue; United States National Institutes of Health; Universities; user-friendly; Weight